Sunday, September 30, 2012

Pilot Study Drug Controls Blood Sugar in People with HI | The Children's Hospital of Philadelphia

›
The standard treatment for some forms of congenital HI is diazoxide (right structure), a drug that controls insulin secretion by openin...
Saturday, September 29, 2012

Hint of tafamidis benefit in rare polyneuropathy

›
The results of a randomized trial suggest that tafamidis treatment may slow the progression of early-stage V30M transthyretin familial amy...
Friday, September 28, 2012

Developing the First Novel Drug Regimen from TB Alliance...

›
TB Alliance’s push to test new drugs in combination has been done to produce a regimen that not only would be faster and easier for patien...

Chemical makes blind mice see; compound holds promise for treating humans

›
The chemical, called AAQ (see below structure,    acrylamide- azobenzene - quaternary ammonium ),  acts   by taking the remaining, normal...
Thursday, September 27, 2012

The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections

›
New research conducted by biologists at Texas A&M University suggests that  sertraline  (see structure below,  ZOLOFT®), one ...
Wednesday, September 26, 2012

Rapamycin effective in mouse model of inherited heart disease and muscular dystrophies

›
In continuation of my update on Rapamycin (Sirolimus) ... Rapamycin , an immunosuppressant drug used in a variety of disease i...
1 comment:
Tuesday, September 25, 2012

Once-daily Gralise significantly reduces pain intensity in PHN patients

›
Depomed, Inc. announced that a report of Phase 3 data published online this month, ahead of the print edition,  in the Clinical Journal o...
Monday, September 24, 2012

New agents, Antimicrobial peptides, join the fight against antibiotic-resistant bacteria

›
Line Hein-Kristensen worked with a new class of antimicrobial agents, the so-called antimicrobial peptides. Antimicrobial peptides are par...
Sunday, September 23, 2012

Memantine, Drug Shown to Improve Memory in Those With Down Syndrome

›
In continuation of my update on   memantine Costa, an associate professor of medicine, and his colleagues studied 38 adolescents and you...
Saturday, September 22, 2012

Eliquis Receives Positive Opinion from CHMP | News | Drug Discovery and Development Magazine

›
In continuation of my update on Apixaban Eliquis  Receives Positive Opinion from CHMP | News | Drug Discovery and Development Magazine

New drug candidate shows promise against cancer - MIT Media Relations

›
Drugs containing platinum are among the most powerful and widely used cancer drugs. However, such drugs have toxic side effects, and cance...
Friday, September 21, 2012

GEN | News Highlights:Green Tea and Gold Nanoparticles Destroy Prostate Tumors

›
In continuation of my update on green tea Scientists report on the development of a radioactive gold nanoparticle for  prostate cancer...
1 comment:
Thursday, September 20, 2012

Scientists develop new strategy to overcome drug-resistant childhood cancer

›
Researchers at The Institute of Cancer Research in London have found a way to overcome the resistance of cancer cells to a drug called cri...
Wednesday, September 19, 2012

Cylene's Pol I inhibitor, CX-5461 activates p53 and selectively destroys cancer cells

›
Cylene Pharmaceuticals  announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia ha...
Tuesday, September 18, 2012

Merck's Phase III trial assessing fracture risk reduction with odanacatib..

›
Merck announced   an update on the Phase III trial assessing fracture risk reduction with odanacatib, (a cathepsin K/cat-K inhibitor see s...